ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 268965 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 268965; 2) Community: the network communities that were significantly associated with the response to NSC 268965; 3) Molecule: the relationships between components within communities and NSC 268965; 4) MDR: the compounds that were significantly associated with the NSC 268965.

NSC Compound Enrichment Correlation
NSC 135687 5.beta.-Bufa-20,22-dienolide, 14,15.beta.-epoxy-3.beta.,5-dihydroxy-, 3-acetate (8CI) 0.0164116791870034 0.28660546
NSC 148790 Card-20(22)-enolide, 16-(acetyloxy)-3,14-dihydroxy-, (3.beta.,5.beta.,16.beta.)- (9CI) 0.0164116791870034 0.43153414
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.0164116791870036 0.27507216
NSC 45236 Null 0.0164116791870036 0.3178816
NSC 603071 Aminocamptothecin 0.0164116791870036 0.57957183
NSC 639501 Cyclopentanone, 2-pentylidene-5-[(1-piperidinyl)methyl]- hydrochloride 0.0164116791870036 0.037366902
NSC 643846 Null 0.0164116791870036 0.17192408
NSC 673652 2-Ethylaminoestradiol 0.0164116791870036 0.042276572
NSC 673787 Null 0.0164116791870036 -0.14696743
NSC 681641 Camptothecin Derivative 0.0164116791870036 0.43805572
Total:50  Current:15    [First] [Prev] [Next] [Last]